(→COVID) Tag: Reverted |
|||
| Line 127: | Line 127: | ||
**"Glantz’s meta-analysis is not just junk science because of details about the studies, though those are problems in themselves. It is junk science because there are probably not even two of the studies in his collection that are similar enough to average together, let alone all of them." (Phillips) | **"Glantz’s meta-analysis is not just junk science because of details about the studies, though those are problems in themselves. It is junk science because there are probably not even two of the studies in his collection that are similar enough to average together, let alone all of them." (Phillips) | ||
*Referring to: Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016 Feb;4(2):116-28. [https://pubmed.ncbi.nlm.nih.gov/26776875/ doi: 10.1016/S2213-2600(15)00521-4]. Epub 2016 Jan 14. PMID: 26776875; PMCID: PMC4752870. | *Referring to: Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016 Feb;4(2):116-28. [https://pubmed.ncbi.nlm.nih.gov/26776875/ doi: 10.1016/S2213-2600(15)00521-4]. Epub 2016 Jan 14. PMID: 26776875; PMCID: PMC4752870. | ||
==COPD== | |||
===2022: Comments RE: [https://pubpeer.com/publications/075B90E6B4FEB1AF3BB188690C317F Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017]=== | |||
*The study by Osei et al. is deficient and unreliable, because it used the Behavioral Risk Factor Surveillance Survey, which contains no information about when participants started to smoke or vape, or when they were diagnosed with chronic obstructive pulmonary disease (COPD). (Radu) | |||
*Referring to: Osei AD, Mirbolouk M, Orimoloye OA, Dzaye O, Uddin SMI, Benjamin EJ, Hall ME, DeFilippis AP, Bhatnagar A, Biswal SS, Blaha MJ. Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017. Am J Prev Med. 2020 Mar;58(3):336-342. doi: 10.1016/j.amepre.2019.10.014. Epub 2020 Jan 2. PMID: 31902685; PMCID: PMC9843649. | |||
==COVID== | ==COVID== | ||
edits